Related Experiment Video
Updated: Jul 20, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
Phenothiazinium derivatives for pathogen inactivation in blood products
Mark Wainwright1, Harald Mohr, Wolfram H Walker
1School of Pharmacy and Chemistry, James Parsons Building, Liverpool John Moores University, Liverpool L3 3AF, UK. mark_wainwright@hotmail.com
Abstract:
Phenothiazine-based photosensitisers have been employed in photoantimicrobial research for nearly 80 years, both as lead and novel compounds. However, the main structural variations have mainly involved the auxochromic side chains and little has been reported concerning either peripheral substitution or structures with chromophores other than those of the phenothiazinium or annelated benzo[a]phenothiazinium type. In terms of application, the phenothiazinium series has featured commonly in cytology and cytopathology, as well as in haematological staining. The current work covers the evolution of improved photosensitisers based on the phenothiazine ring system, with particular reference to the field of pathogen inactivation, and the structural alteration of lead compounds such as methylene blue and Nile blue to yield improved photosensitisers for this important aspect of blood product safety.
Related Concept Videos
Antiprotozoal Agents
Anthelminthic Agents
Hand hygiene
Hand washing...
Chemical Agents for Microbial Control
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling

